Perinatal Support Washington
Seattle, Washington, 98103, United States
NCT Number: NCT06746337
The goal of this clinical trial is to evaluate if a digital group intervention (named IMAGINE) can prevent depression in perinatal populations. The main questions it aims to answer are:
Does IMAGINE engage cognitive behavioral therapy targets? Does IMAGINE lead to lower depression scores? Is IMAGINE acceptable, appropriate, usable and feasible?
Participants will be randomized to either participate in an IMAGINE group for 12 weeks or receive standard of care. Participants will respond to questionnaires at enrollment and study visits at 12 and 24 weeks after enrollment.
This study is active but is not currently recruiting participants.
16 year and older
Female
Interventional
Not applicable
Seattle, Washington, 98103, United States
Perinatal depression affects an estimated 13% of pregnant people in the US. While effective interventions exist to prevent perinatal depression, access to facility-based in-person interventions is limited. This proposal will refine a digital group adaptation of an evidence-based prevention intervention, and evaluate its preliminary effectiveness and implementation outcomes through a pilot randomized controlled trial.
The proposal consists of 3 specific aims:
Aim 1. Using human-centered design, refine the IMAGINE intervention for implementation within perinatal mental health services in Washington State. Building off existing IMAGINE intervention materials, we will conduct qualitative interviews and focus groups with perinatal people, service providers, administrators, and payers to refine:
Hypothesis: Combined synchronous and asynchronous content and delivery compliant with billable health services will be preferred.
Aim 2. Determine IMAGINE's preliminary effectiveness engaging CBT targets and preventing depression.
A pilot RCT will be conducted comparing IMAGINE (as optimized in Aim 1) delivered in English or Spanish vs. treatment as usual, among 100 perinatal participants (pregnant or ≤6 months postpartum) with one or more risk factors for perinatal depression (as defined by USPSTF) and no current major depression. Participants will be recruited from our partner organization's clients. We will compare longitudinal change in depression symptoms and engagement of target mechanisms (negative mood regulation, perceived stress, and perceived social support) between arms at enrollment, 12- and 24-weeks post-enrollment. Exploratory analyses will assess effect modification by participant age, race/ethnicity, pregnancy status, and language.
Hypothesis: IMAGINE will lead to moderate reduction in depression symptoms, with effect size similar to MB.
Aim 3. Determine IMAGINE's preliminary implementation outcomes (acceptability, appropriateness, usability, and feasibility) among client, provider, administrator, and payer stakeholders.
Acceptability, appropriateness and usability among RCT participants will be assessed based on quantitative questionnaires, engagement in IMAGINE, and qualitative interviews. Provider, administrator, and payer acceptability, feasibility, and appropriateness will be determined through group discussion of IMAGINE RCT process indicators. We will explore client and contextual determinants of implementation outcomes.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
none
IMAGINE is a digital group cognitive behavioral therapy intervention
Time frame: 24 weeks
Ascertained by Beck Depression Inventory (score 0-63, higher score means worse outcome)
Time frame: 24 weeks
Ascertained by Patient Health Questionnaire 9 (score 0-27, higher score means worse outcome)
Time frame: 24 weeks
Ascertained by Generalized Anxiety Disorder 7 (score 0-21, higher score means worse outcome)
Time frame: 24 weeks
Ascertained by Negative Mood Regulation Scale (score 30-150, higher score means better outcome)
Time frame: 24 weeks
Ascertained by Medical Outcomes Survey (score 0-100, higher score means better outcome)
Time frame: 24 weeks
Ascertained by Perceived Stress Scale 10 (score 0-40, higher score means worse outcome)
Time frame: 24 weeks
Ascertained by Behavioral Activation for Depression Scale (score 0-150, higher score means better outcome)
Time frame: 24 weeks
Ascertained by Experiences Questionnaire (score 20-100, higher score means better outcome)
University of Washington
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06664593
Anxiety, Anxiety Disorder/Anxiety State
Ghent, Belgium
View Trial DetailsNCT07227753
Behavior, Behavioral Symptoms
Boston, Massachusetts, United States
View Trial DetailsNCT07170124
Behavior, Behavioral Symptoms
Bingoel, Bingöl, Turkey (Türkiye)
View Trial DetailsNCT07279311
Behavior, Behavioral Symptoms
Palo Alto, California, United States
View Trial Details